Post-hoc pairwise group comparisons indicate that pTau/Tau was significantly higher in AKAP9+ subjects within both AD cases (β = 0.22, p = 2.61 × 10−6) and cognitively normal controls (β = 0.19, p = 0.00065). This evidence concerns the gene AKAP9 and Alzheimer disease.